
Femtech Market Report 2026
Global Outlook – By Type (Devices, Software, Services, Other Types), By End Use (Direct-To-Consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers), By Application (Reproductive Health, Pregnancy And Nursing Care, Pelvic And Uterine Healthcare, General Healthcare And Wellness, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2030
Femtech Market Overview
• Femtech market size has reached to $46.47 billion in 2025 • Expected to grow to $118.99 billion in 2030 at a compound annual growth rate (CAGR) of 20.8% • Growth Driver: Femtech Market Growth Fueled By Surging Healthcare Expenditure • Market Trend: Consumer Insights Platform to Innovate Women's Health Solutions • North America was the largest region in 2025.Market Gains By 2030 – Top Opportunities By Segment
Market Gain identifies the most promising market opportunities by highlighting the segments or products expected to generate the highest incremental revenue growth over the next five years.
What Is Covered Under Femtech Market?
The femtech are technology to support women's health which uses software, diagnostics, products, and services to cater to female biological needs. The main types of femitech are devices, software, services, and others. Devices refer to a wide range of tools and products that are used for women's health improvement, consisting of wearable devices, treatment devices, and others. Software is used in female technological products for women's wellness and women's healthcare. Services include medical services that are used in women's healthcare, which are comprised of therapy services used in wellness and healthcare. The various end-users of femtech include direct-to-consumer, hospitals, fertility clinics, surgical centers, and diagnostic centers for applications such as reproductive health, pregnancy and nursing care, pelvic and uterine healthcare, general healthcare and wellness, and others.
What Is The Femtech Market Size and Share 2026?
The femtech market size has grown exponentially in recent years. It will grow from $46.47 billion in 2025 to $55.88 billion in 2026 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to rising awareness of women health issues, smartphone health app adoption, growth of digital health platforms, early fertility tracking tools, increasing healthcare spending.What Is The Femtech Market Growth Forecast?
The femtech market size is expected to see exponential growth in the next few years. It will grow to $118.99 billion in 2030 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be attributed to precision medicine adoption, AI driven health insights, expansion of telehealth services, wearable device innovation, rising investment in women focused startups. Major trends in the forecast period include personalized women health platforms, digital fertility tracking, remote prenatal monitoring, wearable health devices for women, telehealth based gynecology services.
Global Femtech Market Segmentation
1) By Type: Devices, Software, Services, Other Types 2) By End Use: Direct-To-Consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers 3) By Application: Reproductive Health, Pregnancy And Nursing Care, Pelvic And Uterine Healthcare, General Healthcare And Wellness, Other Applications Subsegments: 1) By Devices: Wearable Devices, Diagnostic Devices, Reproductive Health Devices, Menstrual Health Devices, Pregnancy Monitoring Devices 2) By Software: Mobile Applications, Health Tracking Software, Telehealth Platforms, Data Analytics Tools 3) By Services: Consulting Services, Healthcare Provider Services, Support And Educational Services, Subscription Services 4) By Other Types: Community Platforms, Research And Development Services, Health And Wellness Programs The top segments in the femtech market will be: • Software will reach $42.7 billion by 2030. • Devices will reach $34.03 billion by 2030. • Services will reach $26.51 billion by 2030. • Other Types will reach $15.16 billion by 2030.What Is The Driver Of The Femtech Market?
Growing healthcare spending is expected to boost the growth of the femtech market going forward. Healthcare spending refers to the total expenditures made by individuals, governments, and organizations within a specific region or country on healthcare-related goods and services. Increased healthcare spending stimulates investment in research, development, and adoption of innovative women's health technologies within the femtech market, enhancing accessibility to cutting-edge products and services for women's health and well-being. For instance, according to National Health Expenditures Accounts (NHEA) by KFF, a US-based independent source for health policy research, polling and journalism, health spending in the USA is expected to rise by 5% from 2023 to 2024, reaching $4.9 trillion. Therefore, the growing healthcare spending is driving the growth of the femtech industry.
Infographic Chart Showing Key Market Drivers Analysis And Restraints For Femtech Market
The chart presents an impact analysis of key drivers and restraints, quantifying their relative influence on the market's growth rate and helping assess the balance between growth enablers and limiting factors. This chart offers a high-level perspective; the full report contains more detailed insights.
How Will The Drivers Impact Growth In The Global Femtech Market?
• Growing Awareness Of Women’s Health And Reproductive Wellness (High) – During the forecast period, the growing awareness of women’s health and reproductive wellness is expected to become a key growth driver for the femtech market by 2030. Increasing education and advocacy around menstrual health, fertility, menopause, and overall well -being are encouraging women to adopt digital health solutions and preventive care tools. Consumers are becoming more proactive in managing their health, supported by accessible mobile applications and wearable technologies that provide real -time insights. Healthcare providers and organizations are also investing in awareness campaigns and targeted solutions to address historically underserved areas of women’s health. This shift toward proactive and informed healthcare decision -making is reinforcing steady market expansion. • Increasing Demand For Reproductive And Maternal Healthcare Solutions (High) – During the forecast period, the increasing demand for reproductive and maternal healthcare solutions is expected to emerge as a major factor driving the expansion of the femtech market by 2030. Rising fertility challenges, delayed pregnancies, and increasing focus on maternal health are driving demand for advanced solutions such as fertility tracking, pregnancy monitoring, and postpartum care platforms. Technological advancements are enabling more accurate diagnostics, remote consultations, and personalized care plans, improving patient outcomes. Additionally, healthcare systems are increasingly emphasizing preventive and continuous care models, further boosting demand for femtech solutions. • Advancements In Digital Health Technologies (Low) – During the forecast period, advancements in digital health technologies are expected to act as a key growth catalyst for the femtech market by 2030. Innovations in artificial intelligence, big data analytics, wearable devices, and telemedicine platforms are transforming the way women access and manage healthcare services. These technologies enable real-time health tracking, predictive diagnostics, and personalized treatment recommendations, enhancing overall healthcare efficiency and accessibility. The increasing integration of digital platforms with healthcare systems is also improving patient engagement and data-driven decision-making. As digital health ecosystems continue to evolve, adoption of femtech solutions is expected to accelerate significantly.How Will The Restraints Impact Growth In The Global Femtech Market?
• Regulatory Issues (Medium) – During the forecast period, the regulatory issues act as a major restraint for the femtech market because many products such as reproductive health devices, fertility trackers, and diagnostic solutions must comply with strict healthcare regulations. Companies are often required to conduct clinical trials and obtain regulatory approvals before launching their products. These processes increase development costs and extend product launch timelines. In addition, different regulatory frameworks across countries make international expansion more complex. As a result, regulatory barriers slow innovation and delay the commercialization of new femtech solutions. • Lack Of Research And Clinical Validation (High) – During the forecast period, the lack of research and clinical validation restrains the femtech market because women’s health has historically been underrepresented in medical research. This creates knowledge gaps that limit the development of scientifically proven femtech products. Without strong clinical evidence, many solutions struggle to gain approval from healthcare regulators and acceptance from medical professionals. This also reduces trust among consumers and healthcare providers. Consequently, insufficient research slows adoption and market expansion. • Fragmented Healthcare Systems (High) – During the forecast period, the fragmented healthcare systems limit the growth of the femtech market because many femtech applications operate independently from traditional healthcare infrastructure. Lack of integration with hospital systems and electronic health records makes it difficult for healthcare providers to use femtech tools in clinical practice. This disconnect reduces the ability of doctors to incorporate femtech solutions into patient care. As a result, the overall effectiveness and adoption of these technologies remain limited. Poor system integration therefore slows widespread market adoption.Key Players In The Global Femtech Market
Major companies operating in the femtech market are Totohealth Inc.; LifeSense Group; Lumenis Ltd.; Maven Clinic; Kindbody Fertility & Women's Health; Flo Health Inc.; Minvera Health Inc.; Natural Cycles; NURX Inc.; BioWink GmbH; Elvie Inc.; Nuvo Group LLC; Lia Diagnostics Inc.; Bloomlife Inc.; Kasha Global Inc.; Proov; Athena Feminine Technologies; Ava Science Inc.; Joylux Inc.; MedAnswers; OCON Healthcare LLC; Flyte by Pelvital; Inne Inc.; Tia Health; Gennev; iSono Health Inc.; OOVA Inc.; Sera Prognostics Inc.; Cora Health Inc.; HeraMED Inc.; Sustain Natural; LactApp Women’s Health; Trak Fertility; Willow Pump Company; Yono Labs; Zava
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.

This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Global Femtech Market Trends and Insights
Major companies operating in the femtech market are focused on developing technologically advanced solutions, such as consumer insights and research platforms, to enhance innovation in the women's health sector. A consumer insights and research platform is a digital tool or service that collects, analyzes, and interprets consumer data to understand preferences, behaviors, and trends, enabling businesses to make informed decisions and tailor their marketing strategies effectively. For instance, in June 2024, Unfabled, a UK-based women's health platform, launched Unfabled Labs, a consumer insights and research platform, aimed at enhancing innovation in the women's health sector. By leveraging data from over 400,000 women and non-binary individuals, the platform seeks to address the gender health gap and inform the creation of tailored products and services.What Are Latest Mergers And Acquisitions In The Femtech Market?
In March 2023, Maven Clinic, a US -based provider of virtual maternity and women's health services, acquired Naytal for an undisclosed amount. With this acquisition, Maven Clinic aimed to accelerate its expansion in fertility and family care services by integrating Naytal's personalized fertility and pregnancy planning programs into its digital health platform. Naytal is a UK-based provider femtech solutions.
Regional Insights
North America was the largest region in the femtech market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Femtech Market?
The femtech market includes revenues earned by entities by providing period tracker, fertility tracking and solutions, menstruation products, prenatal and postnatal care products, and reproduction healthcare products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.

This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
What Key Data and Analysis Are Included in the Femtech Market Report 2026?
The femtech market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the femtech industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Femtech Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $55.88 billion |
| Revenue Forecast In 2030 | $118.99 billion |
| Growth Rate | CAGR of 20.8% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Type, End Use, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Totohealth Inc.; LifeSense Group; Lumenis Ltd.; Maven Clinic; Kindbody Fertility & Women's Health; Flo Health Inc.; Minvera Health Inc.; Natural Cycles; NURX Inc.; BioWink GmbH; Elvie Inc.; Nuvo Group LLC; Lia Diagnostics Inc.; Bloomlife Inc.; Kasha Global Inc.; Proov; Athena Feminine Technologies; Ava Science Inc.; Joylux Inc.; MedAnswers; OCON Healthcare LLC; Flyte by Pelvital; Inne Inc.; Tia Health; Gennev; iSono Health Inc.; OOVA Inc.; Sera Prognostics Inc.; Cora Health Inc.; HeraMED Inc.; Sustain Natural; LactApp Women’s Health; Trak Fertility; Willow Pump Company; Yono Labs; Zava |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
